The HESA Rebound Initiative Yields Exceptional Pass Rate

The HESA Rebound Initiative Yields Exceptional Pass Rate

Through hybrid tutoring and strong collaboration, the Rebound Initiative helped students with trailing courses succeed in supplementary exams—achieving an exceptional pass rate.

This was a program meticulously designed to provide academic support for students with trailing courses from the 2023/2024 academic year, helping them prepare for supplementary examinations. The initiative employed a hybrid model, combining online and in-person tutoring sessions held at laboratory spaces at the Faculty of Pharmacy and Pharmaceutical Sciences.

The program spanned 40 days and was executed in two phases, each preceded by a publicity period. The tutorials for the first phase ran from September 30th to October 22nd, 2024, and the second phase took place from November 13th to 30th, 2024.

Notably, the initiative reached all HESA academic platforms and class pages, engaging 62 online and 85 in-person participants.  Although there were initial challenges with online delivery–which were addressed through voice notes and video lessons–the in-person sessions were highly successful and well-received.

The initiative was strengthened by a vital partnership with the HESA Welfare Committee. The evaluation of the program yielded a rating of 7/10, indicating room for improvement in online delivery and coordination. This, however, does not diminish the significant outcome: a 100% pass rate among participants, with many scoring exceptionally high marks.

Samuel Owusu, the Academic Board head, described this result as "a truly historic outcome." Participants demonstrated their sincere appreciation to the facilitators: the HESA President (Samuel Tampanga Wepeah), the HESA Welfare Committee Head (Kwame Antwi), Departmental Academic Heads, and all members of the HESA Academic Board for their immeasurable contributions.

This was undeniably a remarkable initiative.

 

Reported by – Franklin Boison (MSA)

The Health Sciences Chronicle

Comments (0)

Leave a Comment

No comments yet. Be the first to comment!